ICU Medical, Inc. (ICUI)
169.85
-0.96
(-0.56%)
USD |
NASDAQ |
Sep 02, 16:00
172.42
+2.57
(+1.51%)
Pre-Market: 08:05
ICU Medical Research and Development Expense (TTM) : 86.32M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 86.32M |
| March 31, 2026 | 85.48M |
| December 31, 2025 | 87.50M |
| September 30, 2025 | 88.76M |
| June 30, 2025 | 88.54M |
| March 31, 2025 | 90.06M |
| December 31, 2024 | 88.62M |
| September 30, 2024 | 88.67M |
| June 30, 2024 | 88.51M |
| March 31, 2024 | 87.42M |
| December 31, 2023 | 85.34M |
| September 30, 2023 | 86.38M |
| June 30, 2023 | 88.61M |
| March 31, 2023 | 88.87M |
| December 31, 2022 | 92.98M |
| September 30, 2022 | 82.70M |
| June 30, 2022 | 71.84M |
| March 31, 2022 | 60.66M |
| December 31, 2021 | 47.50M |
| September 30, 2021 | 46.13M |
| June 30, 2021 | 44.02M |
| March 31, 2021 | 42.91M |
| December 31, 2020 | 42.95M |
| September 30, 2020 | 43.74M |
| June 30, 2020 | 45.61M |
| Date | Value |
|---|---|
| March 31, 2020 | 46.53M |
| December 31, 2019 | 48.61M |
| September 30, 2019 | 49.55M |
| June 30, 2019 | 50.73M |
| March 31, 2019 | 53.10M |
| December 31, 2018 | 52.87M |
| September 30, 2018 | 53.22M |
| June 30, 2018 | 52.81M |
| March 31, 2018 | 52.20M |
| December 31, 2017 | 51.25M |
| September 30, 2017 | 40.03M |
| June 30, 2017 | 30.91M |
| March 31, 2017 | 21.28M |
| December 31, 2016 | 12.96M |
| September 30, 2016 | 14.36M |
| June 30, 2016 | 14.94M |
| March 31, 2016 | 14.72M |
| December 31, 2015 | 15.71M |
| September 30, 2015 | 16.74M |
| June 30, 2015 | 17.56M |
| March 31, 2015 | 19.01M |
| December 31, 2014 | 18.33M |
| September 30, 2014 | 16.71M |
| June 30, 2014 | 14.80M |
| March 31, 2014 | 14.14M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Baxter International, Inc. | 480.00M |
| Becton, Dickinson & Co. | 1.135B |
| Boston Scientific Corp. | 2.153B |
| Glaukos Corp. | 177.17M |
| Medline, Inc. | -- |